Anti-IL-23 monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-IL-23 monoclonal antibody, covering 2025-01-24 to 2025-01-24. Get the full timeline:
Most recent: Clinical Trial Update: Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)